Takafumi Nakagaki - Publications

Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 22, 2025

Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients.

Journal: Oral oncology

Published: November 20, 2019

Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 19, 2018

Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: June 18, 2017

Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.

Journal: Cancer science

Published: May 31, 2017

Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.

Journal: Oncotarget

Published: January 23, 2017

Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.

Journal: Oncotarget

Published: January 29, 2016

Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.

Journal: World journal of gastroenterology

Published: July 28, 2015

CRKL oncogene is downregulated by p53 through miR-200s.

Journal: Cancer science

Published: January 09, 2015